Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-mabHD vs ABVD in Hodgkin's Disease
NCT00797472Phase 2Unknown
- Sponsor
- American Scitech International
- Start
- Jul 2011
- Primary completion
- Apr 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in Hodgkin lymphoma (HL), sponsored by American Scitech International. Status: unknown.
02
Drugs
rituximab
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00797472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00797472.